USA |NASDAQ |USD
Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
---|---|---|---|---|
Nov 2, 2022 | Sep 2022 | - | - | $-0.17 |
Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
---|---|---|---|---|
Nov 2, 2022 | Sep 2022 | - | - | $86.00K |
Cardiff Oncology's next earnings date is Wednesday, Nov 2, 2022 for the fiscal quarter ending Sep 2022.
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Dec 2022 | 4 | $-0.92 | $-1.15 | $-0.68 |
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|
Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
---|---|---|---|---|
Dec 2022 | 0 / 0 | $-0.92 | $-0.92 | $-1.01 |
Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
---|
Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
---|---|---|---|---|
Dec 2022 | 4 | $150.00K | $0.00 | $400.00K |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Aug 3, 2022 | Jun 2022 | $-0.25 | - | - |
May 5, 2022 | Mar 2022 | $-0.23 | $-0.25 | -8.70% |
Feb 24, 2022 | Dec 2021 | $-0.17 | $-0.23 | -35.29% |
Nov 4, 2021 | Sep 2021 | $-0.17 | $-0.17 | - |
Aug 5, 2021 | Jun 2021 | $-0.15 | $-0.17 | -13.33% |
May 6, 2021 | Mar 2021 | $-0.15 | $-0.14 | 5.08% |
Feb 25, 2021 | Dec 2020 | $-0.14 | $-0.08 | 42.86% |
Nov 5, 2020 | Sep 2020 | $-0.19 | $-0.19 | -1.77% |
Aug 11, 2020 | Jun 2020 | $-0.24 | $-0.51 | -112.50% |
May 7, 2020 | Mar 2020 | - | $-0.41 | - |
Feb 27, 2020 | Dec 2019 | $-0.65 | $-0.51 | 21.54% |
Nov 7, 2019 | Sep 2019 | $-0.84 | $-0.71 | 15.48% |
Aug 8, 2019 | Jun 2019 | $-1.02 | $-0.79 | 22.55% |
May 7, 2019 | Mar 2019 | $-1.07 | $-1.02 | 4.67% |
Mar 6, 2019 | Dec 2018 | $-0.65 | $-1.09 | -67.69% |
Nov 7, 2018 | Sep 2018 | $-1.98 | $-1.08 | 45.45% |
Aug 3, 2018 | Jun 2018 | $-1.98 | $-2.76 | -39.39% |
May 8, 2018 | Mar 2018 | $-5.76 | $-6.48 | -12.50% |
Feb 26, 2018 | Dec 2017 | $-9.36 | $-4.32 | 53.85% |
Nov 9, 2017 | Sep 2017 | $-10.08 | $-8.64 | 14.29% |
Aug 9, 2017 | Jun 2017 | $-10.80 | $-18.72 | -73.33% |
May 10, 2017 | Mar 2017 | $-17.28 | $-23.04 | -33.33% |
Mar 15, 2017 | Dec 2016 | $-23.04 | $-20.16 | 12.50% |
Nov 9, 2016 | Sep 2016 | $-23.76 | $-24.48 | -3.03% |
Aug 4, 2016 | Jun 2016 | $-24.24 | $-24.48 | -0.99% |
May 10, 2016 | Mar 2016 | $-23.40 | $-25.20 | -7.69% |
Mar 10, 2016 | Dec 2015 | $-22.32 | $-18.72 | 16.13% |
Nov 9, 2015 | Sep 2015 | $-0.27 | $-0.10 | 62.96% |
Aug 10, 2015 | Jun 2015 | $-0.24 | $-0.41 | -70.83% |
May 5, 2015 | Mar 2015 | $-0.24 | $-0.33 | -37.50% |
Mar 12, 2015 | Dec 2014 | $-0.25 | $-0.25 | - |
Nov 6, 2014 | Sep 2014 | $-0.24 | $-0.28 | -16.67% |
Aug 7, 2014 | Jun 2014 | $-14.88 | $-4.32 | 70.97% |
May 12, 2014 | Mar 2014 | $-14.04 | $-12.24 | 12.82% |
Mar 17, 2014 | Dec 2013 | $-13.68 | $-3.60 | 73.68% |
Nov 14, 2013 | Sep 2013 | $-16.20 | $-18.00 | -11.11% |
Aug 14, 2013 | Jun 2013 | $-10.44 | $-10.80 | -3.45% |
Apr 1, 2013 | Mar 2013 | $-6.12 | $-7.20 | -17.65% |
Mar 31, 2013 | Dec 2012 | $-6.12 | $-7.20 | -17.65% |
Nov 28, 2012 | Sep 2012 | - | $-3.35 | - |
Aug 29, 2012 | Jun 2012 | - | $-20.47 | - |
Mar 31, 2012 | Mar 2012 | - | $-7.67 | - |
Dec 31, 2011 | Dec 2011 | - | $-9.32 | - |
Sep 30, 2011 | Sep 2011 | - | $-0.00 | - |
Jun 30, 2011 | Jun 2011 | - | $-4.12 | - |
Mar 31, 2011 | Mar 2011 | - | $-3.94 | - |
Jun 30, 2010 | Jun 2010 | - | $-6.21 | - |
Mar 31, 2010 | Mar 2010 | - | $-4.44 | - |
Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
---|---|---|---|---|
Feb 24, 2022 | Dec 2021 | $-0.66 | $-0.71 | - |
Feb 25, 2021 | Dec 2020 | $-1.09 | $-1.19 | - |
Feb 27, 2020 | Dec 2019 | - | $-3.03 | - |
Mar 6, 2019 | Dec 2018 | - | $-11.41 | - |
Feb 26, 2018 | Dec 2017 | - | $-54.72 | - |
Mar 15, 2017 | Dec 2016 | - | $-94.32 | - |
Mar 10, 2016 | Dec 2015 | - | $-19.56 | - |
Mar 12, 2015 | Dec 2014 | - | $-17.09 | - |
Mar 17, 2014 | Dec 2013 | - | $-39.60 | - |
Mar 31, 2013 | Dec 2012 | - | $-38.69 | - |
Dec 31, 2011 | Dec 2011 | - | $-28.02 | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Aug 3, 2022 | Jun 2022 | - | - | - |
May 5, 2022 | Mar 2022 | - | $74.00K | - |
Feb 24, 2022 | Dec 2021 | $30.00K | $133.00K | 4.43% |
Nov 4, 2021 | Sep 2021 | $30.00K | $86.00K | 2.87% |
Aug 5, 2021 | Jun 2021 | $150.00K | $68.00K | 0.45% |
May 6, 2021 | Mar 2021 | $150.00K | $72.00K | 0.48% |
Feb 25, 2021 | Dec 2020 | $0.00 | $119.25K | - |
Nov 5, 2020 | Sep 2020 | $30.00K | $136.40K | 4.55% |
Aug 11, 2020 | Jun 2020 | $0.00 | $42.63K | - |
May 7, 2020 | Mar 2020 | $0.00 | $67.70K | - |
Feb 27, 2020 | Dec 2019 | - | $92.58K | - |
Nov 7, 2019 | Sep 2019 | - | $51.69K | - |
Aug 8, 2019 | Jun 2019 | - | $138.28K | - |
May 7, 2019 | Mar 2019 | - | $161.96K | - |
Mar 6, 2019 | Dec 2018 | - | $78.02K | - |
Nov 7, 2018 | Sep 2018 | - | $88.36K | - |
Aug 3, 2018 | Jun 2018 | - | $111.81K | - |
May 8, 2018 | Mar 2018 | - | $100.14K | - |
Feb 26, 2018 | Dec 2017 | - | $185.03K | - |
Nov 9, 2017 | Sep 2017 | - | $123.33K | - |
Aug 9, 2017 | Jun 2017 | - | $102.01K | - |
May 10, 2017 | Mar 2017 | - | $95.04K | - |
Mar 15, 2017 | Dec 2016 | - | $68.07K | - |
Nov 9, 2016 | Sep 2016 | - | $89.11K | - |
Aug 4, 2016 | Jun 2016 | - | $103.40K | - |
May 10, 2016 | Mar 2016 | - | $120.49K | - |
Mar 10, 2016 | Dec 2015 | - | $79.17K | - |
Nov 9, 2015 | Sep 2015 | - | $57.33K | - |
Aug 10, 2015 | Jun 2015 | - | $49.35K | - |
May 5, 2015 | Mar 2015 | - | $126.97K | - |
Mar 12, 2015 | Dec 2014 | - | $56.40K | - |
Nov 6, 2014 | Sep 2014 | - | $57.20K | - |
Aug 7, 2014 | Jun 2014 | - | $55.63K | - |
May 12, 2014 | Mar 2014 | - | $110.95K | - |
Mar 17, 2014 | Dec 2013 | - | $47.37K | - |
Nov 14, 2013 | Sep 2013 | - | $43.76K | - |
Aug 14, 2013 | Jun 2013 | - | $49.00K | - |
Apr 1, 2013 | Mar 2013 | - | $119.12K | - |
Mar 31, 2013 | Dec 2012 | - | $163.25K | - |
Nov 28, 2012 | Sep 2012 | - | $211.50K | - |
Aug 29, 2012 | Jun 2012 | - | $41.50K | - |
Mar 31, 2012 | Mar 2012 | - | $34.15K | - |
Dec 31, 2011 | Dec 2011 | - | $33.75K | - |
Sep 30, 2011 | Sep 2011 | - | $55.00K | - |
Jun 30, 2011 | Jun 2011 | - | $79.86K | - |
Mar 31, 2011 | Mar 2011 | - | $89.08K | - |
Jun 30, 2010 | Jun 2010 | - | $20.00K | - |
Mar 31, 2010 | Mar 2010 | - | - | - |
Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
---|---|---|---|---|
Feb 24, 2022 | Dec 2021 | $200.00K | $359.00K | 79.50% |
Feb 25, 2021 | Dec 2020 | $366.00K | $365.99K | -0.00% |
Feb 27, 2020 | Dec 2019 | - | $244.63K | - |
Mar 6, 2019 | Dec 2018 | - | $378.32K | - |
Feb 26, 2018 | Dec 2017 | - | $505.40K | - |
Mar 15, 2017 | Dec 2016 | - | $381.07K | - |
Mar 10, 2016 | Dec 2015 | - | $312.81K | - |
Mar 12, 2015 | Dec 2014 | - | $280.18K | - |
Mar 17, 2014 | Dec 2013 | - | $259.25K | - |
Mar 31, 2013 | Dec 2012 | - | $450.40K | - |
Dec 31, 2011 | Dec 2011 | - | $257.70K | - |
CRDF's next earnings date is Wednesday, Nov 2, 2022 for the fiscal quarter ending Sep 30, 2022.
Cardiff Oncology's previous earnings date was Aug 3, 2022 for its fiscal quarter ended Jun 30, 2022.
Cardiff Oncology's previous annual earnings date was Feb 24, 2022 for its fiscal year ended Dec 31, 2021.
CRDF's earnings per share (EPS) was $-0.71, missing the consensus analysts forecast of $-0.66 by 7.58% , and higher than the previous year's EPS (Dec 2020) by -40.34%.
Revenues were $359.00K, better than the forecast of $200.00K by 79.50%, and down by -1.91% from previous year's revenue.
The company reported a net income of $-28.29M.
Cardiff Oncology reported a free cash flow of $-23.25M for its fiscal year, compared to $-16.53M a year ago.
The company ended the fiscal year with $3.12M in total debt, an increase of 258.71% compared to the previous year.